ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1655

Usability Testing of JIActiv, an Instagram-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis

Zeinab Ahmadian Sangkar1, Fatou Bagayogo2, Karina Cristea2, Ciaran Duffy3, Jennifer Stinson4, Karine Toupin April3, Michele Gibbon5, Marianne Boulet1, Élodie Bolduc1, Aymane Alilou6, Sara Ahmed7, Claudine Auger1, Laurie Proulx8, Alexandra Sirois9 and Sabrina Cavallo10, 1University of Montreal, Montreal, QC, Canada, 2CRIR, Montreal, QC, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Children's Hospital of Eastern Ontario RI, Ottawa, ON, Canada, 6Unviersity of Montreal, Montreal, QC, Canada, 7McGill University, Montreal, QC, Canada, 8Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, 9CARRA, Outremont, QC, Canada, 10University of Montreal, Montréal, QC, Canada

Meeting: ACR Convergence 2023

Keywords: health behaviors, Health Care, Juvenile idiopathic arthritis, Occupational therapy, physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Interprofessional Exemplary

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: This study evaluated the usability (user performance and satisfaction) of an Instagram-based educational and interactive program promoting physical activity among young people living with juvenile idiopathic arthritis (JIA).

Methods: A descriptive qualitative study design was used. A convenience sample of adolescents and young adults (13 to 25 years) with JIA (n = 28; mean age = 18.69, SD=± 2.28 years) was recruited from arthritis-patient organizations, rehabilitation, and hospital centers to participate in two iterative cycles of online (Zoom platform) semi-structured interviews. The audio recordings of the interviews were transcribed verbatim, sorted, organized, and coded using the MAXQDA 11 software. The interview questions were grouped into 10 main categories including: 1. Privacy and Safety, 2. Design Aesthetics, 3. Functionalities, 4. Organization of the program, 5. Content of page, 6. Motivating factors, 7. Willingness to follow the program, 8. Language display (preferences),9. Suggestions for improvement to the JIActiv program and 10. Willingness to recommend the program.

Results: All participants used a computer, a smartphone or a tablet to access and navigate the JIActiv program. Overall, participants did not report any significant concerns about privacy and safety while using the JIActiv program. Participants provided positive feedback regarding the program’s user-friendly navigation and appealing visual design. Most participants reported that the featured information was relevant and of good quality. They appreciated the structure of the intervention program (overall length of the program, frequency of posts and weekly time requirements). The interactive features supporting group-based activities were highly appreciated as they offered opportunities to communicate and share information and experiences with peers. Peer interactions and the opportunity to communicate with healthcare providers were identified as motivating factors to use the JIActiv program. Some participants suggested shortening the videos length and presenting English and French content on separate Instagram pages, however this was not identified as a barrier to the use of the program. Participants suggested some minor modifications to the program. Based on these, modifications were implemented after each cycle if semi-structured interviews including edits to the informational videos to facilitate navigation.

Conclusion: Findings showed that the JIActiv program demonstrated good usability. This testing has allowed us to optimize end users’ (young people with JIA) ability to access, to navigate, to understand and to implement the informational content and practical strategies featured through this program in a culturally competent, efficient and satisfying manner.


Disclosures: Z. Ahmadian Sangkar: None; F. Bagayogo: None; K. Cristea: None; C. Duffy: None; J. Stinson: None; K. Toupin April: None; M. Gibbon: None; M. Boulet: None; É. Bolduc: None; A. Alilou: None; S. Ahmed: None; C. Auger: None; L. Proulx: AbbVie/Abbott, 5, ESDC, 5, IMC, 5; A. Sirois: None; S. Cavallo: None.

To cite this abstract in AMA style:

Ahmadian Sangkar Z, Bagayogo F, Cristea K, Duffy C, Stinson J, Toupin April K, Gibbon M, Boulet M, Bolduc É, Alilou A, Ahmed S, Auger C, Proulx L, Sirois A, Cavallo S. Usability Testing of JIActiv, an Instagram-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/usability-testing-of-jiactiv-an-instagram-based-program-promoting-engagement-in-physical-activity-among-young-people-living-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usability-testing-of-jiactiv-an-instagram-based-program-promoting-engagement-in-physical-activity-among-young-people-living-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology